MEDX HEALTH CORP (MDX.CA) Stock Income Statement
TSX-V:MDX - TSX Venture Exchange - CA5850901037 - Common Stock - Currency: CAD
| TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 388.70K | 456.10K | 510.60K | 563.10K | 530.10K | |||
| Cost Of Goods | 233.90K | 270.50K | 270.70K | 289.80K | 262.00K | |||
| Gross Profit | 154.70K | 185.60K | 240.00K | 273.30K | 268.10K | |||
| Operating Expenses | 3.10M | 3.21M | 4.11M | 4.84M | 3.30M | |||
| Research and Development | 514.60K | 586.10K | 681.80K | 995.40K | 431.20K | |||
| Selling, General, and Administrative Expenses | 2.55M | 2.59M | 3.39M | 3.81M | 2.79M | |||
| Operating Income | -2.95M | -3.02M | -3.87M | -4.56M | -3.03M | |||
| Interest Income/Expense | -1.47M | -2.15M | -1.27M | -784.20K | -70.20K | |||
| Non Recurring Items | N/A | 597.80K | 0.00 | 23.40K | -99.90K | |||
| Income Before Taxes | -3.82M | -4.58M | -5.13M | -5.32M | -3.20M | |||
| Net Income | -3.82M | -4.58M | -5.13M | -5.32M | -3.20M | |||
| EBITDA | -2.90M | -2.97M | -3.82M | -4.51M | -2.95M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -0.02 | -0.02 | -0.03 | -0.03 | -0.02 | |||
| Statistics | ||||||||
| Gross Profit Margin | 39.80% | 40.69% | 47.00% | 48.53% | 50.58% | |||
| Profit Margin | -983.28% | -1004.30% | -1005.42% | -945.39% | -603.57% | |||
| Operating Profit Margin | -759.02% | -663.23% | -757.62% | -810.30% | -571.48% | |||
All data in CAD